This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immudex Aps. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Amir Ameri: Innovator in MHC Multimer Technology
Introduction
Amir Ameri is a notable inventor based in Vanløse, Denmark. He has made significant contributions to the field of immunology through his innovative work on MHC multimers. His research focuses on the detection of specific T cells and the diagnosis, treatment, and monitoring of diseases in individuals.
Latest Patents
Amir Ameri holds a patent for a "Panel comprising MHC multimers." This patent discloses a panel that includes one or more MHC multimers, as well as pools of MHC multimers. Each pool consists of one or more MHC multimers that contain an antigenic peptide derived from selected antigenic polypeptides, including OppA, DbpA, FlhF, FlaB, and P37-42. The applications of this technology are crucial for advancing medical diagnostics and therapeutic strategies.
Career Highlights
Amir Ameri is currently associated with Immudex Aps, where he continues to develop innovative solutions in the field of immunology. His work has positioned him as a key player in the advancement of MHC multimer technology.
Collaborations
Amir collaborates with talented professionals such as Liselotte Brix and Kivin Jacobsen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Amir Ameri's contributions to the field of immunology through his patent on MHC multimers highlight his role as an influential inventor. His work not only enhances our understanding of immune responses but also paves the way for improved diagnostic and therapeutic approaches.